Gregory Piazza
Brigham and Women's Hospital · 489 works · 16,474 citations · h-index 60
Top works
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
- A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism
- Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association
- Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
- Chronic Thromboembolic Pulmonary Hypertension
- A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism
- Correlates of Bleeding Events Among Moderate- to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide
- The Acutely Decompensated Right Ventricle
- Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
- Fat Embolism Syndrome
- Cerebral Venous Thrombosis
- Thromboangiitis Obliterans
- Acute Pulmonary Embolism
- Multidisciplinary Pulmonary Embolism Response Teams
- Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study
- Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development
- Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy
- Acute Pulmonary Embolism
- Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19